Point72 Asset Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29M Buy
410,400
+392,500
+2,193% +$29.4M 0.04% 624
2025
Q4
$1.41M Buy
17,900
+17,700
+8,850% +$1.4M ﹤0.01% 2688
2025
Q3
$16.5K Buy
+200
New +$15.7K ﹤0.01% 2252
2025
Q1
Sell
-8,000
Closed -$655K 2340
2024
Q4
$655K Sell
8,000
-12,900
-62% -$1.07M ﹤0.01% 1588
2024
Q3
$1.72M Buy
20,900
+17,300
+481% +$1.29M ﹤0.01% 1250
2024
Q2
$253K Hold
3,600
﹤0.01% 1573
2024
Q1
$267K Buy
+3,600
New +$251K ﹤0.01% 1820

Other funds holding MET

Point72 Asset Management's MET Position: Q1 2026 in Review

Point72 Asset Management sold out of MetLife (MET) in Q1 2026, closing a stake of 969,063 shares — an estimated $72.6M sold.

Point72 Asset Management first reported a position in MET in Q3 2016 and held it in 25 quarters. The position peaked at $76.5M in Q4 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Point72 Asset Management reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 969,063 MetLife shares in Q1 2026, an estimated $72.6M.
  • Point72 Asset Management first reported a position in MetLife in Q3 2016 and held it in 25 quarters.
  • Point72 Asset Management's MetLife position peaked at $76.5M in Q4 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.